Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Durata Therapeutics, Inc. (DRTX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Durata Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1544116.
Total stock buying since 2014: $320,355.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $20,940.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2014 | 21,000 | $320,355 | 0 | $0 | 10,068 | $20,940 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2014-08 | 3,000 | $41,160 | 0 | $0 | 10,068 | $20,940 |
2014-06 | 3,000 | $45,690 | 0 | $0 | 0 | $0 |
2014-05 | 15,000 | $233,505 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-08-26 | Canaan Viii Lp (Director) | Option Ex | 5,034 | 2.08 | 10,470 |
2014-08-26 | Ahrens Brenton Karl (Director) | Option Ex | 5,034 | 2.08 | 10,470 |
2014-08-12 | Shannon John Patrick Jr (Chief Commercial Officer) | Buy | 3,000 | 13.72 | 41,160 |
2014-06-12 | Edick Paul R (Chief Executive Officer) | Buy | 3,000 | 15.23 | 45,690 |
2014-05-12 | De Schutter Richard U (Director) | Buy | 15,000 | 15.57 | 233,505 |
Insider trading activities including stock purchases, stock sales, and option exercises of DRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Durata Therapeutics, Inc. (symbol DRTX, CIK number 1544116) see the Securities and Exchange Commission (SEC) website.